Menopause: What Helps and What to Ask Your Doctor

One woman describes waking every night with a hot flash, only to leave her appointment without discussing its impact. Another senses discomfort when she brings up vaginal dryness and lower sexual desire. These accounts published onlinedescribe a specific difficulty: seeking medical help and leaving without understanding the options.

Outside the examination room, answers seem plentiful. People share experiences, recommend supplements and debate hormones. Hearing from other women can help you recognize what is happening. Deciding what to do also requires an assessment of your symptoms, their impact and the options supported by evidence.

As a family physician, I believe most routine menopause care can and should happen in family medicine. That responsibility requires training, time for discussion and follow-up. You should have room to explain what has changed, understand your choices and agree on a plan that works for your life.

The essentials in 30 seconds

• Symptoms can begin while you still have periods and deserve attention when they affect your life.
• Family medicine can handle much routine care and coordinate more complex cases.
• Hormone and nonhormone treatments are chosen according to symptoms, risks and preferences.
• Folic acid has encouraging preliminary findings but insufficient evidence to recommend it for hot flashes.
• Vaginal dryness, insomnia and prevention deserve attention whether you use hormones or not.

Symptoms can start before your final period

Natural menopause is recognized after twelve months without a menstrual period, when another cause does not explain the change. Symptoms can begin earlier, during the transition: irregular periods, hot flashes, night sweats or trouble sleeping. As a review in Nature Reviews Disease Primers explains, experiences vary and are also shaped by health and personal circumstances.

Some women need information and support; others seek relief from symptoms disrupting daily life. Waiting until periods have stopped can delay a useful conversation.

For women age 45 and older with a typical history, the diagnosis is usually clinical, based on symptoms and menstrual changes. Menopause practice standards explain that a hormone panel generally is not needed to confirm it. Testing may be appropriate when the diagnosis is uncertain, symptoms begin earlier or another condition needs to be investigated.

A useful evaluation also considers medications, medical history, sleep and mood. The timing of a symptom helps guide the discussion while leaving room to assess what is causing it.

Hormone therapy: who it helps and why

Systemic hormone therapy—treatment that acts throughout the body—is the most effective treatment for bothersome hot flashes and night sweats. The American College of Physicians (ACP), in its guideline published in October 2026, recommends it as the first medication option when appropriate.

If you have a uterus, systemic estrogen generally needs to be paired with a progestogen to protect the uterine lining. The balance is usually more favorable for women younger than 60 or within ten years of menopause who have no contraindications. Formulation, delivery method and duration also matter. Potential harms include blood clots, stroke and, with certain regimens, a higher risk of breast cancer, as outlined in the 2022 hormone therapy position statement.

The history of these treatments needs context. A 2024 review in JAMA explains that the major trials studied particular oral products in women of different ages. Their findings support treating bothersome symptoms in selected women in early menopause; they do not justify prescribing hormones to everyone.

Symptom relief and general disease prevention are different decisions. The U.S. Preventive Services Task Force (USPSTF) recommends against hormone therapy for preventing chronic conditions in postmenopausal people without symptoms who are considering it for that purpose. That recommendation does not address treating hot flashes.

The conversation should clarify what improvement you want, your individual risks and the alternatives. Hormone therapy should not be presented as a guarantee of youth, memory protection or heart attack prevention.

Options for hot flashes, vaginal dryness and sexual desire

If you prefer to avoid hormones or have a contraindication, nonhormonal medications with evidence behind them are available. They include venlafaxine, certain other antidepressants, gabapentin and medications targeting neurokinin pathways involved in temperature regulation. The ACP guideline organizes these alternatives according to the evidence and tolerance of earlier options.

They also have side effects and monitoring requirements. Gabapentin can cause drowsiness; fezolinetant requires liver monitoring. A review in JAMA Internal Medicine discusses these choices. Cost, insurance coverage and access to follow-up should also be part of the decision.

Vaginal dryness and pain during sex deserve their own conversation. Lubricants may help during sexual activity, while vaginal moisturizers are used regularly. When local hormone treatment is needed, low-dose vaginal estrogen has a strong evidence base, according to the 2025 guideline on genitourinary syndrome of menopause. Exposure elsewhere in the body is much lower than with systemic therapy.

Sexual desire requires an assessment of pain, sleep, mood, medications and relationships. The international consensus on testosterone therapy for women recognizes a modest benefit for some postmenopausal women whose low desire causes personal distress, after a comprehensive evaluation. Long-term safety remains uncertain; evidence does not support prescribing it simply to boost energy or overall well-being.

Does folic acid help with hot flashes?

A Cuban reader told me that folic acid had helped her greatly during the menopause transition and that her hot flashes had disappeared. Another reader said hers had not stopped completely but estimated a 50–70% reduction. These personal accounts deserve to be heard and raise a reasonable question about a product some women already use.

Those percentages describe one reader’s perceived improvement; they cannot tell us how much another woman would benefit. Attributing the change to a supplement requires comparing it with what happens without it, while allowing for symptoms changing over time.

Research offers encouraging signals, though insufficient evidence. A small study published in 2010 reported improvement with folic acid, but its size and design limitations prevented a convincing conclusion about effectiveness.

A 2021 trial in BJOG compared 5 mg daily for twelve weeks with placebo in 164 postmenopausal women with normal folate levels. Both groups improved, without a statistically clear advantage for folic acid on the primary measure combining hot-flash frequency and severity. Some quality-of-life measures improved at eight weeks, a secondary finding needing confirmation. The study’s size limits certainty. 

Current evidence does not support recommending folic acid as an established hot-flash treatment. Questions remain, and positive personal experiences cannot resolve them. The Menopause Society’s 2023 statement on nonhormonal options also does not recommend supplements and herbal remedies as treatments for these symptoms.

Dose matters, too. A review of folic acid and vitamin B12 warns that high doses can correct anemia and mask B12 deficiency while neurological problems persist. If you already take it, bring the bottle to your appointment and discuss why it was recommended, the amount it contains and whether further evaluation is appropriate.

What healthy habits can do for your health

Physical activity, strength training, a healthy eating pattern and smoking cessation support heart, muscle and bone health. A scientific statement in Circulation identifies the menopause transition as an opportunity to assess cardiovascular risk and address factors that can be changed.

Promising that more walking or a better diet will resolve hot flashes would go beyond the evidence. Exercise and dietary changes alone have not shown consistent relief. Continuing symptoms do not mean you have failed at caring for yourself.

Cognitive behavioral therapy can reduce how bothersome and disruptive hot flashes feel. Persistent insomnia may benefit from a specific form of this treatment. A randomized trial found benefits when it was delivered by telephone, offering a possible route to care where in-person services are limited.

What family medicine should offer

Your family physician can evaluate the diagnosis, assess risks, discuss options, prescribe when appropriate and check your progress. They can also coordinate specialist input for concerns such as a history of breast cancer, blood clots, diagnostic uncertainty or symptoms that do not respond. Collaboration should reflect the complexity of your situation.

That work requires training. A U.S. survey published in 2019, using data collected in 2017, found that only 12 of 177 residents answering that question felt prepared to manage menopause. Participants trained in family medicine, internal medicine, and obstetrics and gynecology. It documents a gap in that sample, not the preparation of all physicians today.

The visit also provides an opportunity to review bone health, blood pressure, cholesterol, blood glucose, mood and cancer screening appropriate to age and medical history. The American Family Physician review of health maintenance after menopause places prevention within comprehensive care, whether you choose hormones or another approach.

There should be a follow-up date. Practice standards recommend assessing the response around three months after treatment begins and at least annually afterward, with timing adjusted to individual needs. A prescription starts an ongoing evaluation.

Three steps you can take this week

1. Write down what has changed and how it affects you. Track hot flashes, awakenings, menstrual changes or vaginal discomfort for a few days. Include the consequences: fatigue at work, pain during sex or activities you no longer enjoy.
2. Schedule a menopause-focused visit with your family physician. Bring your medications and supplements, including folic acid if you use it, and choose your two biggest concerns to discuss first.
3. Leave with a clear next step. Ask which options fit, what benefits and risks they carry, what they cost and when the response will be reviewed. The plan may involve treatment, information or further evaluation.

When further evaluation matters

If menstrual changes and symptoms suggest menopause before age 45, particularly before 40, a specific evaluation is needed. Bleeding after menopause also requires assessment, even when light: its cause needs to be investigated, as a systematic review of postmenopausal bleeding illustrates.

If you use hormone therapy, report changes in bleeding so your clinician can decide what evaluation fits your regimen and circumstances. Persistent symptoms, painful sex or insomnia also justify revisiting the plan.

The woman waking every night deserves a question about what happens afterward: whether she falls asleep again, how she feels in the morning and what it takes to get through the day. Readers who found relief also deserve an honest explanation of what we know. Good care can create a path toward better rest, more comfortable intimacy and more energy for what matters, with decisions that belong to you, too.

Scientific sources

These sources support the information in this article and are available for readers who would like to explore the topic further.

Key readings

1. Qaseem A, Mackey K, Yost J, et al. Pharmacologic Treatments for Females With Menopausal Vasomotor Symptoms: A Clinical Guideline From the American College of Physicians. Ann Intern Med. 2026. doi:10.7326/ANNALS-26-01205.
2. The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause.2022;29(7):767–794. doi:10.1097/GME.0000000000002028.
3. Ewies AAA, Ahmed I, Al-Azzawi F, et al. Folic acid supplementation in postmenopausal women with hot flushes: phase III randomised double-blind placebo-controlled trial. BJOG. 2021;128(12):2024–2033. doi:10.1111/1471-0528.16739.

Additional scientific sources

4. North American Menopause Society. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573–590. doi:10.1097/GME.0000000000002200.
5. Hamoda H, Moger S, Morris E, et al. Menopause practice standards. Clin Endocrinol (Oxf). 2024. doi:10.1111/cen.14789.
6. Davis SR, Lambrinoudaki I, Lumsden M, et al. Menopause. Nat Rev Dis Primers. 2015;1:15004. doi:10.1038/nrdp.2015.4.
7. Manson JE, Crandall CJ, Rossouw JE, et al. The Women’s Health Initiative Randomized Trials and Clinical Practice: A Review. JAMA. 2024;331(20):1748–1760. doi:10.1001/jama.2024.6542.
8. US Preventive Services Task Force. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement. JAMA.2022;328(17):1740–1746. Recommendation.
9. Huang AJ, Faubion S, Grady D. Nonhormonal Treatment of Menopausal Vasomotor Symptoms. JAMA Intern Med.2025;185(7):874–875. doi:10.1001/jamainternmed.2025.0990.
10. Kaufman MR, Ackerman AL, Amin KA, et al. The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. J Urol. 2025;214(3):242–250. doi:10.1097/JU.0000000000004589.
11. Davis SR, Baber R, Panay N, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Clin Endocrinol Metab. 2019;104(10):4660–4666. doi:10.1210/jc.2019-01603.
12. McCurry SM, Guthrie KA, Morin CM, et al. Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial. JAMA Intern Med. 2016. Article.
13. El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation. 2020;142:e506–e532. doi:10.1161/CIR.0000000000000912.
14. Plesa M, Wong A, Katsaggelos E. Health Maintenance in Postmenopausal Women. Am Fam Physician.2025;111(5):407–418. Article.
15. Kling JM, MacLaughlin KL, Schnatz PF, et al. Menopause Management Knowledge in Postgraduate Family Medicine, Internal Medicine, and Obstetrics and Gynecology Residents: A Cross-Sectional Survey. Mayo Clin Proc. 2019;94(2):242–253. doi:10.1016/j.mayocp.2018.08.033.
16. Clarke MA, Long BJ, Del Mar Morillo A, et al. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis. JAMA Intern Med. 2018;178(9):1210–1222. doi:10.1001/jamainternmed.2018.2820.
17. Gaweesh SS, Abdel-Gawad MM, Nagaty AM, et al. Folic acid supplementation may cure hot flushes in postmenopausal women: a prospective cohort study. Gynecol Endocrinol. 2010;26(9):658–662. doi:10.3109/09513591003686288.
18. Miller JW, Smith A, Troen AM, et al. Excess Folic Acid and Vitamin B12 Deficiency: Clinical Implications? Food Nutr Bull. 2024;45(1_suppl):S67–S72. doi:10.1177/03795721241229503.

Journalistic sources and personal accounts

• Dominus S. Women Have Been Misled About Menopause. The New York Times Magazine. February 1, 2023. Source of the online accounts described in the opening.
• Accounts shared with Dr. Dan by two readers and provided for this article. Personal communications without public links; they are not evidence that folic acid is effective.